mariusmozaAssisi DentaLOOP® Therapy Device: Clinical Protocols for Veterinary Dental Pain Management
Managing pain after dental extractions — whether a single tooth or a full-mouth procedure — is one of the more complex challenges in day-to-day veterinary practice. Standard analgesic protocols often force a difficult tradeoff: push the pharmacology hard enough to achieve adequate relief, and you risk adverse effects and client compliance failures; pull back, and the patient suffers. Veterinary dental pain management deserves a better option.
The Assisi® DentaLOOP® targeted PEMF therapy device was developed to address exactly this gap. Clinical research demonstrates that targeted Pulsed Electromagnetic Field (tPEMF™) therapy can reduce opioid requirements by approximately 50% while improving patient comfort and recovery outcomes — making it a meaningful addition to multimodal dental pain management protocols for both dogs and cats.
With periodontal disease affecting 80% of canine and 70% of feline patients by age three, dental procedures constitute a significant and growing portion of practice caseload. This clinical guide provides veterinary protocols for integrating the DentaLOOP® therapy device into dental practice, from routine extractions through complex orofacial surgery and chronic inflammatory conditions.
Clinical Key Point
tPEMF therapy does not replace your existing analgesic protocol — it enhances it. The goal is multimodal pain management: better outcomes with less pharmacological burden on the patient.
The Clinical Challenge: Dental Pain Management in Veterinary Practice
Postoperative dental pain management presents layered challenges that affect patient welfare, client satisfaction, and practice efficiency simultaneously. Understanding where standard protocols fall short is the foundation for building a better approach.
Medication-Related Challenges
Even well-designed analgesic protocols encounter real-world limitations in the dental patient population. The most common include:
- Inadequate pain control despite standard analgesic protocols, particularly in complex extractions or full-mouth cases
- Adverse drug reactions — gastrointestinal effects from NSAIDs are among the most frequently reported complications in postoperative dental patients
- Polypharmacy concerns in geriatric or medically compromised patients, where drug interactions and organ function limitations constrain options
- Regulatory and ethical pressures around opioid prescribing, which continue to tighten across the veterinary profession
Client Compliance Issues
Even when a pharmacological protocol is clinically sound, its effectiveness depends on client execution at home. Common compliance barriers include:
- Poor adherence with multi-drug regimens, particularly when dosing schedules are complex or frequent
- Difficulty administering oral medications to patients who are already painful and reluctant to be handled around the mouth
- Polypharmacy concerns in geriatric or medically compromised patients, where drug interactions and organ function limitations constrain options
- Cost concerns when multiple pharmaceutical interventions are prescribed simultaneously
Limited Options for Chronic Oral Conditions
Chronic inflammatory conditions of the oral cavity present a particularly difficult management challenge. Conditions including feline chronic gingivostomatitis (FCGS), canine chronic ulcerative paradental stomatitis (CUPS), and oral eosinophilic granuloma complex require long-term pain and inflammation management — and long-term pharmacological approaches carry cumulative hepatotoxic and nephrotoxic risks that limit what is safe to sustain. Practitioners managing these cases need options that can be used consistently over time without compounding organ burden.
The Science Behind tPEMF™ Therapy for Veterinary Dental Pain
Targeted PEMF therapy works through documented cellular mechanisms — this is not a generic energy therapy. The DentaLOOP device delivers the same tPEMF signal that has been used and validated in veterinary medicine for over 15 years, now optimized specifically for oral and maxillofacial anatomy.
Mechanism of Action
The tPEMF signal enhances endogenous nitric oxide (NO) production through the endothelial nitric oxide synthase (eNOS) pathway. This triggers a cascade of anti-inflammatory and analgesic effects at the cellular level, including:
- Reduction in pro-inflammatory cytokine activity
- Direct pain modulation through the nitric oxide signaling pathway
- Improved local circulation and tissue perfusion at the treatment site
- Accelerated tissue healing and resolution of inflammation
Clinical trials have demonstrated approximately 50% reduction in opioid requirements with tPEMF therapy, with anti-inflammatory effects comparable to NSAIDs in standard inflammation models — without the associated gastrointestinal, hepatic, or renal risks.
What Distinguishes the DentaLOOP® from Generic PEMF Devices
Not all PEMF devices are equivalent. The DentaLOOP therapy device is the only targeted PEMF device specifically configured to target the nitric oxide signaling pathway. Generic PEMF devices deliver non-optimized signals that do not consistently reach the therapeutic threshold required to activate the eNOS pathway. The distinction matters clinically: the mechanism only functions reliably when the signal parameters are correct.
The DentaLOOP is backed by over 15 years of clinical use in veterinary medicine, with peer-reviewed research published in JAAHA and other veterinary journals — making it the most extensively validated targeted PEMF device available for veterinary practice.
Clinical Application: The DentaLOOP Therapy Device
The DentaLOOP adapts the proven tPEMF signal for oral and maxillofacial applications. Each battery-powered device delivers 60 fifteen-minute treatment sessions with automatic shutoff — designed for straightforward use by both in-clinic staff and clients at home. An optional DentaLOOP Bonnet (available in small, medium, and large) enables hands-free application, reducing handling demands for both patient and owner.
Clinical Indications: Postoperative Pain Management
The DentaLOOP therapy device is indicated across the full spectrum of veterinary dental and oral surgical procedures:
- Single or multiple tooth extractions
- Full-mouth extractions
- Periodontal surgery, including flaps and guided tissue regeneration
- Orofacial surgery: mandibulectomy, maxillectomy, rostral mandibulectomy
- Oral tumor resection
- Traumatic oral injuries
Clinical Indications: Chronic Inflammatory Conditions
For patients requiring long-term inflammation and pain management, the DentaLOOP therapy device offers a non-pharmacological option that can be sustained over time without cumulative organ risk:
- Feline chronic gingivostomatitis (FCGS)
- Canine chronic ulcerative paradental stomatitis (CUPS)
- Oral eosinophilic granuloma complex
- Chronic periapical inflammation
Evidence-Based Protocols for Integrating the DentaLOOP
The following protocols are designed to integrate the DentaLOOP therapy device into existing multimodal pain management frameworks. The device complements rather than replaces current analgesic protocols — the goal is enhanced outcomes with reduced pharmacological burden.
Protocol 1: Routine Single or Multiple Tooth Extractions
For straightforward extraction cases, the DentaLOOP therapy device is most commonly deployed postoperatively, though pre-procedural use can reduce baseline inflammation in patients with significant periodontal disease.
- Preoperative (optional): Begin DentaLOOP sessions 3–5 days before the procedure, twice daily, 15 minutes per session. Particularly beneficial in patients with active periodontitis or significant gingival inflammation.
- Intraoperative: Maintain standard anesthetic protocol with local nerve blocks. Multimodal analgesia — opioid, NSAID, local anesthetic — is still recommended alongside tPEMF therapy.
- Postoperative: Begin DentaLOOP sessions as soon as the patient has recovered from anesthesia. Two to four 15-minute sessions daily for the first 3–5 days, then twice daily through the recheck period.
- Client instruction: Discharge the device with the patient. The DentaLOOP Bonnet simplifies home use for clients who may struggle with manual positioning. Demonstrate application before discharge.
Protocol 2: Full-Mouth Extractions
Full-mouth extractions represent the highest-demand postoperative pain management scenario in veterinary dentistry — and the clinical context where the DentaLOOP therapy device offers the most meaningful benefit.
- Preoperative: Begin DentaLOOP therapy 5–7 days prior to the procedure when possible, twice daily. Pre-procedural tissue treatment reduces baseline inflammation and may support better postoperative tissue response.
- Intraoperative: Regional nerve blocks are essential. Full multimodal protocol including opioid intraoperatively; NSAID and additional systemic analgesia per patient assessment.
- Postoperative in-clinic: Initiate DentaLOOP session in recovery. Continue four times daily while hospitalized, if applicable.
- Postoperative at home: Three to four sessions daily for the first 5–7 days, then twice daily for two to three weeks. Use the DentaLOOP Bonnet to facilitate consistent, stress-free home application.
- NSAID tapering: tPEMF therapy may support earlier NSAID tapering in patients who respond well — assess at the 5–7 day recheck and adjust analgesic protocol accordingly.
Protocol 3: Chronic Inflammatory Conditions (FCGS, CUPS, Eosinophilic Granuloma Complex)
Chronic oral inflammatory conditions require a long-term management mindset. The DentaLOOP® therapy device is well-suited to this role because it can be used continuously without the cumulative organ risks associated with prolonged NSAID or corticosteroid use.
- Induction phase: Three to four sessions daily for the first two weeks, 15 minutes per session.
- Maintenance phase: Twice daily sessions ongoing. Reassess comfort, appetite, and oral examination findings at 30-day intervals to evaluate response.
- Integration with other therapies: The DentaLOOP device is compatible with concurrent pharmacological management. In FCGS cases where immunosuppressive therapy is ongoing, tPEMF therapy may allow for dose reduction over time as inflammation improves — work with an internal medicine specialist when adjusting immunosuppressive protocols.
- Client education: Frame DentaLOOP therapy as a long-term component of the oral health management plan, not a short-course treatment. Consistent client adherence is essential to sustained benefit.
Protocol 4: Orofacial Surgery and Oral Tumor Resection
Major oral surgical procedures involve significant tissue trauma and extended postoperative pain burden. The DentaLOOP therapy device supports tissue healing and pain modulation throughout the recovery period characteristic of these cases.
- Preoperative: Begin DentaLOOP therapy 5–7 days before surgery when the oncologic timeline allows.
- Postoperative: Four times daily for the first week, then three times daily through suture removal or wound recheck. Continue twice daily as needed based on clinical assessment.
- Wound healing support: Position the device to cover the surgical site during each session. The tPEMF signal penetrates tissue and does not require direct contact with the wound.
Ready to integrate the Assisi DentaLOOP into your dental protocols?
Learn more at assisi.zomedica.com/dentaloop • Contact us
Practice Integration: What to Expect
Adopting a new modality into clinical workflow raises practical questions. The DentaLOOP therapy device is designed to minimize implementation friction — for your team and your clients.
Staff Training and Workflow
The DentaLOOP requires minimal staff training. Application is straightforward: position the device around the muzzle or facial area, initiate the 15-minute session, and allow the automatic shutoff to complete the treatment. The DentaLOOP Bonnet simplifies positioning for recovery monitoring and reduces the need for staff to remain with the patient during treatment.
Most practices integrate the DentaLOOP device into their existing post-extraction recovery protocol without significant workflow disruption. The device can be initiated in the recovery area and sent home with the patient, creating continuity between in-clinic and at-home care.
Client Communication
Client buy-in is straightforward when the value is framed clearly. Key messages that resonate:
- The DentaLOOP device helps manage pain and inflammation through a non-drug mechanism, which is particularly valuable for patients who have had adverse reactions to medications or who are on complex drug regimens
- It does not replace medications — it works alongside them, with the goal of achieving better comfort with less pharmacological burden
- Home use is simple: the DentaLOOP Bonnet allows for hands-free application with no special handling required
- Practices implementing the DentaLOOP device report improved client confidence in postoperative care and fewer distress-related callbacks in the days following dental procedures, based on practitioner feedback
Elevating Veterinary Dental Pain Management
Veterinary dentistry demands pain management solutions that do not force a choice between efficacy and safety. The DentaLOOP therapy device addresses both — delivering clinically validated anti-inflammatory and analgesic effects through a non-pharmacological mechanism that is compatible with every stage of the dental patient’s treatment, from preoperative tissue preparation through long-term chronic condition management.
As the only targeted PEMF device specifically configured for the nitric oxide signaling pathway and backed by over 15 years of clinical validation in veterinary medicine, the DentaLOOP device offers practitioners confidence in both mechanism and outcomes. Integration requires minimal staff training, fits into existing workflows, and extends the quality of care your practice can offer to dental patients across the full spectrum of complexity.
The result is better patient comfort, stronger client confidence, and a multimodal pain management approach that works harder for your patients — and your team.
©2026 Zomedica Inc. All rights reserved. DENTALOOP® is a registered trademark of Zomedica Inc.
Disclaimer: The information provided on this blog is for general informational and educational purposes only. It is not intended as medical advice and should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before making any health‑related decisions.
